Dyadic International, Inc. (NASDAQ: DYAI), a biotechnology company, announced its participation in the Sidoti Virtual Investor Conference. The event is scheduled for June 4, 2025.
According to the company's press release, Dyadic's management will present a corporate overview and participate in one-on-one meetings with investors. The presentation will highlight the company's C1-cell protein production platform and its applications in vaccines, therapeutics, and other biologics.
The Sidoti conference is a semi-annual event that connects public companies with institutional investors, analysts, and other financial professionals. Dyadic's presentation is expected to focus on recent business developments and strategic initiatives.
Interested parties can register for the conference through Sidoti's website. A replay of the presentation will be available for a limited time following the event.
